ES8702369A1 - Procedimiento para ligar histamina a un soporte - Google Patents

Procedimiento para ligar histamina a un soporte

Info

Publication number
ES8702369A1
ES8702369A1 ES551220A ES551220A ES8702369A1 ES 8702369 A1 ES8702369 A1 ES 8702369A1 ES 551220 A ES551220 A ES 551220A ES 551220 A ES551220 A ES 551220A ES 8702369 A1 ES8702369 A1 ES 8702369A1
Authority
ES
Spain
Prior art keywords
carrier
histamine
bound
hydrogen
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551220A
Other languages
English (en)
Other versions
ES551220A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of ES8702369A1 publication Critical patent/ES8702369A1/es
Publication of ES551220A0 publication Critical patent/ES551220A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA LIGAR HISTAMINA A UN SOPORTE. SE TRATA EN PARTICULAR DE LIGAR COVALENTEMENTE HISTAMINA A UN SOPORTE (I) QUE CONTENGA AL MENOS GRUPOS FUNCIONALES QUE REACCIONEN PARA FORMAR UN ENLACE COVALENTE ENTRE EL DERIVADO Y EL SOPORTE. SUMINISTRO DE RECEPTORES DE HISTAMINA, COMO ANTICUERPOS CON ESPECIFICIDAD PARA HISTAMINA Y METILHISTAMINA Y METODOS INMUNOLOGICOS PARA DETERMINACION Y DETECCION DE HISTAMINA Y DE SUS PRODUCTOS DE DEGRADACION.
ES551220A 1985-01-24 1986-01-24 Procedimiento para ligar histamina a un soporte Expired ES8702369A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8500339A SE8500339L (sv) 1985-01-24 1985-01-24 Berarbundet histamin, dess framstellning och anvendning

Publications (2)

Publication Number Publication Date
ES8702369A1 true ES8702369A1 (es) 1986-12-16
ES551220A0 ES551220A0 (es) 1986-12-16

Family

ID=20358885

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551220A Expired ES8702369A1 (es) 1985-01-24 1986-01-24 Procedimiento para ligar histamina a un soporte

Country Status (6)

Country Link
EP (1) EP0208776A1 (es)
JP (1) JPS62501560A (es)
AU (1) AU5396386A (es)
ES (1) ES8702369A1 (es)
SE (1) SE8500339L (es)
WO (1) WO1986004331A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
DE4025726A1 (de) * 1990-08-14 1992-02-20 Boehringer Mannheim Gmbh Bestimmung von biogenen aminen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2301532A (en) * 1938-08-18 1942-11-10 Parke Davis & Co Biological product and process of obtaining same
US2372066A (en) * 1940-12-23 1945-03-20 Parke Davis & Co Biological product and process of obtaining same
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
GB1316990A (en) * 1970-09-17 1973-05-16 Roche Products Ltd Imidazolyl derivatives
US3873697A (en) * 1972-11-11 1975-03-25 Mack Chem Pharm Histamine antigen
US4016146A (en) * 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
DE3322117A1 (de) * 1983-06-20 1984-12-20 Diamalt AG, 8000 München Verfahren zur herstellung von n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivaten, n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivate und ihre verwendung

Also Published As

Publication number Publication date
AU5396386A (en) 1986-08-13
EP0208776A1 (en) 1987-01-21
JPS62501560A (ja) 1987-06-25
SE8500339L (sv) 1986-07-25
SE8500339D0 (sv) 1985-01-24
WO1986004331A1 (en) 1986-07-31
ES551220A0 (es) 1986-12-16

Similar Documents

Publication Publication Date Title
DE3855816D1 (de) Chromatographisches Material
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
SE8804073L (sv) Maetyta foer anvaendning i biosensorer
DE3586838D1 (de) Kieseltraeger.
HUT50988A (en) Method for obtaining polimer derivates of immunoglobuline g for compensating factors disturbing immunotests
ATE110110T1 (de) Verfahren zum immobilisieren von proteinen, peptiden, coenzymen od.dgl. an einem träger.
AU4769085A (en) Carrier material for use in immune determinations
ATE68371T1 (de) Traegermaterial fuer chromatographische verwendung oder zum ausfuehren von enzymatischen reaktionen.
EP0184454A3 (en) Immobilized antibody systems and their preparation
DE69526521D1 (de) Modulation der immunantwort
EP0194578A3 (en) Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials
CA2135487A1 (en) Heteroaromatic Quinuclidinenes, Their Use and Preparation
ES459656A1 (es) Procedimiento para la obtencion de compuestos cuaternarios.
ES8702369A1 (es) Procedimiento para ligar histamina a un soporte
DE58904672D1 (de) Verfahren zur herstellung einer festphasenmatrix.
AU1856300A (en) Derivatisation of support surfaces
AU2857289A (en) Carrier for the enzymatic or chemical and enzymatic reaction of nucleic acids or nucleic acid fragments on solid phases
ATE60057T1 (de) Verfahren zur herstellung von hexamethylcyclotrisilazan.
DE3580542D1 (de) Chromatographische trennungsprozesse an polypeptidtraegermaterial.
IL100105A0 (en) Supported microspheres
EP0164889A3 (en) Surface-treated polymeric substrates
FR2566720B3 (fr) Support d'articles tels que bouteilles, cassettes, adaptable aux portes de vehicules
SU1349252A1 (ru) Способ получения иммобилизованной фосфолипазы a
FI861321A0 (fi) Foerfaranden foer stabilisering av prostatspecifik antigen i naturella matriser.
ES480624A1 (es) Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506